Evaluating patients with cirrhosis for hepatocellular carcinoma: Value of clinical symptomatology, imaging and alpha-fetoprotein

Oncology

Volumn 72, Issue SUPPL. 1, 2007, Pages 117-123

  Paul, Shashi Bala ^a   Gulati, Manpreet Singh ^a   Sreenivas, Vishnubhatla ^a   Madan, Kaushal ^a   Gupta, Arun Kumar ^a   Mukhopadhyay, Sima ^a   Acharya, Subrat Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Clinical symptomatology; Hepatocellular carcinoma; Screening; Sensitivity; Specificity

Indexed keywords

ALPHA FETOPROTEIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANOREXIA; CANCER DIAGNOSIS; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; JAUNDICE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; UPPER GASTROINTESTINAL BLEEDING; WEIGHT REDUCTION;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIA; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 37149000547     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111717     Document Type: Conference Paper

References (27)

1. Llovet JM, Burroughs A, Bruix J: Hepatocelluar carcinoma. Lancet 2003;362:1907-1917.
2. Fattovich G, Giustina G, Schalm SW, et al: Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B: the EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 1995;21:77-82.
3. Okuda K, Ohtuski T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985;56:918-928.
4. Sarin SK, Thakur V, Guptan RK, et al: Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol 2001;16:666-673.
5. Batra Y, Gulati M, Paul SB, Acharya SK: Clinical profile and results of therapy in patients of HCC at a tertiary care center in India. J Gastroenterol Hepatol 2004;19:A799.
6. Daniele B, Bencivenga A, Megna AS, Tinessa V: Alpha fetoprotein and ultrasonography screening for hepatocelluar carcinoma. Gastroenterology 2004;127:S108-S112.
7. Sherman M: Alphafetoprotein: an obituary. J Hepatol 2001;34:603-605.
8. Bruix J, Sherman M, Llovet JM, et al: EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. European Association for the Study of Liver. J Hepatol 2001;35:421-430.
9. Peterson MS, Baron RL: Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001;5:123-144.
10. Talwalkar JA, Gores GJ: Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 2004;127:S126-S132.
11. Feefey SA, Hildeboldt CC, Dehdashti F, et al: Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 2003;226:533-542.
12. Yao FY, Ferrell L, Bass NM, et al: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size does not adversely impact survival. Hepatology 2001;33:1394-1403.
13. Chalasani N, Horlander JC Sr, Said A, et al: Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999;94:2988-2993.
14. Tanaka S, Kitamura T, Imaoka S, et al: Hepatocellular carcinoma: sonographic and histological correlation. Am J Roentgenol 1983;140:701-707.
15. Tanaka S, Kitamura T, Ahshima A, et al: Diagnostic accuracy of ultrasonography for hepatocellular carcinoma. Cancer 1986;58:344-347.
16. Rao ARW, Chui AKK, Shi LW, et al: Sensitivity of radiological investigations in diagnosing hepatocellular carcinoma in cirrhotic liver. Transplant Proc 2003;35:348-349.
17. Matsumoto Y, Suzuki T, Asadi T, et al: Clinical classification of hepatoma in Japan according to serial charges in serum alpha fetoprotein levels. Cancer 1982;49:354-336.
18. Johnson J: Tumor marker in the diagnosis and management of patients with hepatocullular carcinoma. Recent Results Cancer Res 1986;100:68.
19. Watanabe A, Yamamoto H, Ito T, et al: Diagnosis, treatment and prognosis of small hepatocellular carcinoma. Hepatogastroenterlogy 1986;33:52.
20. Sherman M, Peltekian KM, Lee C: Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North-American urban population. Hepatology 1995;22:432-438.
21. Trevisani F, D'Intino PE, Morselli-Labate AM, et al: Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001;34:570-575.
22. Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD: Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000;95:1535-1538.
23. Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB: Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002;36:410-417.
24. Peng YC, Chan CS, Chen GH: The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Hepatogastroenterology 1999;46:3208-3211.
25. Cedrone A, Covino M, Caturelli E, et al: Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in hepatocellular carcinoma? A study in 350 western patients. Hepatogastroenterology 2000;47:1654-1658.
26. Tong MJ, Blatt LM, Kao VW: Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001;16:553-559.
27. Okuda K, Okuda H: Primary liver cell carcinoma; in Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J (eds): Oxford Textbook of Clinical Hepatology, ed 2. Oxford, Oxford University Press, 1999, vol II, pp 1491-1530.